front 1 CYP-1A2 | back 1 Acetaminophen |
front 2 CYP-2E1 | back 2 Alcohol |
front 3 CYP-2C9 | back 3 Warfarin |
front 4 CYP-2D6 | back 4 Cardiovascular drugs |
front 5 CRAP GPS induces my rage | back 5 ![]() CYP inducers |
front 6 The study of genetic factors that underlie variation in drug response is called: A) Pharmacodynamics B) Pharmacogenomics C) Toxicokinetics D) Pharmaceutics | back 6 B. Pharmacogenomics |
front 7 A linked series of alleles found at a locus on a chromosome is best described as a: A) Haplotype B) Genotype C) Phenotype D) Isoform | back 7 A. Haplotype |
front 8 Phase I enzymes are involved in biotransformation of over what percentage of prescription drugs? A) 25% B) 50% C) 75% D) 95% | back 8 C. 75% |
front 9 In pharmacogenetic nomenclature, each star-allele variation is defined by a specific sequence variation within the gene: A) Promoter B) Locus C) Intron D) Codon | back 9 B. Locus |
front 10 Which CYP enzyme metabolizes beta blockers, antidepressants, antipsychotics, and opioid analgesics? | back 10 CYP2D6 |
front 11 The gene encoding CYP2D6 has over 100 defined alleles, making it highly: A) Conserved B) Polymorphic C) Silent D) Recessive | back 11 B. Polymorphic |
front 12 Patients who are CYP2D6 poor or intermediate metabolizers are more likely to experience insufficient: A) Pain relief B) Bile secretion C) Renal filtration D) Platelet inhibition | back 12 A. Pain relief |
front 13 CYP2D6 ultrarapid metabolizers are at increased risk for which opioid-related outcome? A) Treatment failure B) Side effects C) Delayed absorption D) Reduced activation | back 13 B. Side effects |
front 14 What CYP enzyme preferentially metabolizes acidic drugs, including proton pump inhibitors, antidepressants, antiepileptics, and antiplatelet drugs? | back 14 CYP2C19 |
front 15 The rate-limiting enzyme in pyrimidine catabolism is: A) CYP2D6 B) UGT1A1 C) DPD D) TPMT | back 15 C. DPD |
front 16 Partial deficiency of dihydropyrimidine dehydrogenase can dramatically reduce clearance of which chemotherapy drug? A) Irinotecan B) 5-fluorouracil C) Methotrexate D) Flucloxacillin | back 16 B) 5-fluorouracil |
front 17 UDP glucuronosyltransferase 1A1 helps excrete drugs by conjugating glucuronic acid onto small: A) Protein molecules B) Lipophilic molecules C) Inorganic ions D) Nucleic acids | back 17 B. Lipophilic molecules |
front 18 About 10% of Europeans are homozygous for UGT1A1*28, which is clinically recognized as: A) Gilbert syndrome B) Crigler-Najjar II C) Rotor syndrome D) Dubin-Johnson syndrome | back 18 A. Gilbert syndrome |
front 19 Gilbert syndrome can cause 60–70% increased unconjugated bilirubin because UGT1A1 activity is reduced by about: A) 10% B) 30% C) 60% D) 90% | back 19 B. 30% |
front 20 Which topoisomerase I inhibitor prodrug is first-line with 5-FU and leucovorin for colon or rectal cancer? A) Azathioprine B) Simvastatin C) Irinotecan D) Rasburicase | back 20 C. Irinotecan |
front 21 Irinotecan causes cancer cell death primarily by inhibiting topoisomerase I, leading to termination of: A) DNA replication B) Protein translation C) RNA splicing D) Bilirubin conjugation | back 21 A. DNA replication |
front 22 Which enzyme methylates aromatic and heterocyclic sulfhydryl compounds and deactivates thiopurine drugs? A) G6PD B) TPMT C) DPD D) BCRP | back 22 B. TPMT |
front 23 About 10% of Europeans and Africans inherit one functional TPMT allele and therefore have: A) Absent TPMT activity B) Intermediate TPMT activity C) Excessive TPMT activity D) Normal TPMT activity | back 23 B. Intermediate TPMT activity |
front 24 Azathioprine and 6-mercaptopurine are thiopurine drugs used to treat: A) Immunologic disorders B) Hyperlipidemia C) Opioid toxicity D) Acid reflux | back 24 A. Immunologic disorders |
front 25 The first and rate-limiting enzyme of the pentose phosphate pathway that supplies significant NADPH is: A) CYP2C19 B) OATP1B1 C) G6PD D) UGT1A1 | back 25 C. G6PD |
front 26 G6PD deficiency is defined as enzyme activity below: A) 10% B) 30% C) 60% D) 90% | back 26 C. 60% |
front 27 Most G6PD-deficient genotypes are associated with which severity range? A) Mild and silent B) Moderate and severe C) Severe and lethal D) Mild and moderate | back 27 B. Moderate and severe |
front 28 Patients with G6PD deficiency receiving rasburicase are at increased risk for hemolytic anemia and: A) Methemoglobinemia B) Aplastic anemia C) Sideroblastic anemia D) Megaloblastic anemia | back 28 A. Methemoglobinemia |
front 29 Which transporter is on the hepatocyte sinusoidal membrane and takes up mainly weakly acidic drugs and endogenous compounds? A) BCRP B) OATP1B1 C) P-glycoprotein D) CFTR | back 29 B. OATP1B1 |
front 30 HMG-CoA reductase inhibitors are highly effective lipid-lowering drugs better known as: A) Statins B) Fibrates C) Resins D) Niacins | back 30 A. Statins |
front 31 Patients receiving simvastatin with reduced OATP1B1 function should receive which dose adjustment? A) Higher dose B) Lower dose C) Loading dose D) No dose | back 31 B. Lower dose If OATP1B1 function is reduced: less simvastatin enters liver |
front 32 BCRP is an ATP-binding cassette efflux transporter found on epithelial cells of the kidney, liver, intestine, and endothelial cells of the: A) Blood-brain barrier B) Splenic sinusoids C) Bone marrow D) Cardiac valves | back 32 A. Blood-brain barrier |
front 33 Severe hypersensitivity drug reactions include toxic epidermal necrolysis, Stevens-Johnson syndrome, and which organ injury? A) Kidney injury B) Liver injury C) Lung injury D) Splenic injury | back 33 B. Liver injury |
front 34 Which drug’s hypersensitivity reaction is probably mediated by cytotoxic CD8 T cells? A) Abacavir B) Simvastatin C) Irinotecan D) Digoxin | back 34 A. Abacavir |
front 35 Which phase I drug-metabolizing enzyme acts primarily on acidic drugs, including S-warfarin, phenytoin, and NSAIDs? A) CYP2D6 B) CYP2C9 C) CYP3A4 D) CYP1A2 | back 35 B. CYP2C9 |
front 36 Rare genetic variants in the coding region of VKORC1 may cause bleeding disorders or: A) Codeine toxicity B) Warfarin resistance C) Statin myopathy D) Digoxin accumulation | back 36 B. Warfarin resistance |
front 37 The VKORC1-1639G>A variant occurs most commonly in which population, helping explain ethnic differences in warfarin dosing? A) Asian populations B) African populations C) Northern Europeans D) Native Australians | back 37 A. Asian populations |
front 38 Pharmacogenomics recognizes that drug-response variation may be caused by: A) One vitamin deficiency B) One renal transporter C) Multiple genetic variants D) Only CYP3A4 | back 38 C. Multiple genetic variants |
front 39 Using genetic information to guide drug and dose selection for subgroups or individual patients is called: A) Empiric dosing B) Precision medicine C) Drug tolerance D) First-pass metabolism | back 39 B. Precision medicine |
front 40 Two or more alternative forms of a gene arising by mutation at the same genetic locus are called: A) Alleles B) Haplotypes C) Isoforms D) Promoters | back 40 A. Alleles |
front 41 Allele frequency refers to the percentage of times a specific allele is observed relative to: A) All possible alleles B) All expressed proteins C) All coding SNPs D) All chromosomes | back 41 A. All possible alleles |
front 42 A single base-pair substitution occurring in a coding region is called a: A) Copy number variant B) Coding SNP C) Haplotype D) Linked locus | back 42 B. Coding SNP |
front 43 A DNA segment present in variable copy number between individuals is called a: A) CNV B) nsSNP C) Haplotype D) Locus | back 43 A. CNV |
front 44 A nonsynonymous SNP is a single base-pair substitution that causes a change in: A) Amino acid sequence B) Copy number C) Allele frequency D) Chromosome number | back 44 A. Amino acid sequence |
front 45 Linkage disequilibrium refers to nonrandom association of alleles at two or more loci descended from a single ancestral: A) Drug substrate B) Chromosome C) Protein isoform D) Coding region | back 45 B. Chromosome |
front 46 P450 phase I biotransformation reactions typically modify which parts of endogenous or xenobiotic compounds? A) Functional groups B) Chromosome arms C) Peptide bonds D) Nuclear receptors | back 46 A. Functional groups |
front 47 Which CYP is highly polymorphic, metabolizes about 25% of drugs, and converts codeine to morphine? A) CYP2C9 B) CYP2D6 C) CYP2C19 D) CYP3A5 | back 47 B. CYP2D6 |
front 48 CYP2D6 performs which reaction to convert codeine into morphine? A) O-demethylation B) Glucuronidation C) S-methylation D) Acetylation | back 48 A. O-demethylation |
front 49 Morphine, the active metabolite of codeine, provides analgesia by binding which CNS receptor? A) μ opioid receptor B) GABA-A receptor C) NMDA receptor D) D2 receptor | back 49 A. μ opioid receptor |
front 50 After equal codeine doses, CYP2D6 extensive metabolizers usually experience which outcome? A) Desired analgesic effect B) No drug activation C) Severe bleeding D) Statin toxicity | back 50 A. Desired analgesic effect “Extensive metabolizer” basically means normal metabolizer. |
front 51 After equal codeine doses, CYP2D6 poor and intermediate metabolizers are more likely to experience: A) Insufficient analgesic effects B) Severe warfarin resistance C) Excess morphine toxicity D) Rapid drug clearance | back 51 A. Insufficient analgesic effects |
front 52 After equal codeine doses, CYP2D6 ultrarapid metabolizers have higher risk for side effects such as drowsiness and: A) Respiratory depression B) Bladder cancer C) Mucositis D) Hand-foot syndrome | back 52 A. Respiratory depression |
front 53 Which CYP preferentially metabolizes acidic drugs, including PPIs, antidepressants, antiepileptics, and antiplatelet drugs? A) CYP2D6 B) CYP2C19 C) CYP2B6 D) CYP1A2 | back 53 B. CYP2C19 |
front 54 Clopidogrel is best described as which type of cardiovascular medication? A) Direct thrombin inhibitor B) Thienopyridine antiplatelet prodrug C) Reversible P2Y12 antagonist D) Cyclooxygenase-1 inhibitor | back 54 B. Thienopyridine antiplatelet prodrug |
front 55 Clopidogrel is indicated for prevention of which clinical event category? A) Atherothrombotic events B) Ventricular arrhythmias C) Pulmonary vasospasm D) Biliary obstruction | back 55 A. Atherothrombotic events |
front 56 The active metabolites of clopidogrel inhibit platelet aggregation by selectively and irreversibly blocking which stimulus pathway? A) Thrombin-induced fibrin formation B) ADP-induced platelet aggregation C) Collagen-induced vasospasm D) Prostacyclin-mediated dilation | back 56 B. ADP-induced platelet aggregation |
front 57 About 85% of administered clopidogrel is rapidly converted by hepatic esterases into which products? A) Active thiol metabolites B) Toxic quinone intermediates C) Inactive carboxylic acid derivatives D) Glucuronidated biliary conjugates | back 57 C. Inactive carboxylic acid derivatives |
front 58 About 15% of clopidogrel is converted to its active thiol metabolite through two sequential oxidation reactions mediated mostly by: A) CYP2C19 B) CYP2D6 C) CYP1A2 D) CYP3A5 | back 58 A. CYP2C19 |
front 59 A CYP2C19 *2/*17 patient is not an ultrarapid metabolizer because *17 cannot fully compensate for: A) Increased CYP3A4 activity B) Nonfunctional CYP2C19 alleles C) Excess platelet ADP signaling D) Rapid esterase hydrolysis | back 59 B. Nonfunctional CYP2C19 alleles |
front 60 A patient taking clopidogrel carries CYP2C19 nonfunctional alleles. Which outcome becomes more likely? A) Myelosuppression B) Cardiovascular events C) Gilbert syndrome D) Methemoglobinemia | back 60 B. Cardiovascular events |
front 61 Which phase I enzyme is encoded by the DPYD gene? A) Dihydropyrimidine dehydrogenase B) Thiopurine S-methyltransferase C) UDP glucuronosyltransferase D) Hepatic carboxylesterase | back 61 A. Dihydropyrimidine dehydrogenase |
front 62 DPD is a major elimination route for which chemotherapy drug class? A) Fluoropyrimidine chemotherapy agents B) Platinum alkylating agents C) Antifolate chemotherapy agents D) Anthracycline chemotherapy agents | back 62 A. Fluoropyrimidine chemotherapy agents |
front 63 5-fluorouracil targets rapidly dividing cancer cells primarily by inhibiting: A) DNA synthesis B) Bile secretion C) Platelet activation D) Vitamin K recycling | back 63 A. DNA synthesis |
front 64 Most 5-fluorouracil is catabolized and excreted through which enzyme pathway? A) UGT1A1 glucuronidation B) DPD pyrimidine catabolism C) CYP2D6 O-demethylation D) TPMT S-methylation | back 64 B. DPD pyrimidine catabolism |
front 65 A patient with DPYD *2A/*13 receives 5-fluorouracil. What is the expected pharmacokinetic consequence? A) Increased 5-FU clearance B) Reduced 5-FU clearance C) Complete clopidogrel failure D) Increased bilirubin conjugation | back 65 B. Reduced 5-FU clearance |
front 66 DPD deficiency increases 5-FU toxicity partly by increasing which toxic metabolites? A) SN-38 and bilirubin B) Morphine and thioguanine C) 5-FUMP and 5-FdUMP D) PAPS and acetyl-CoA | back 66 C. 5-FUMP and 5-FdUMP |
front 67 UGT1A1 is a phase II enzyme that conjugates glucuronic acid onto small lipophilic molecules such as: A) Bilirubin B) Codeine C) Warfarin D) Digoxin | back 67 A. Bilirubin |
front 68 UGT1A1-mediated glucuronidation helps small lipophilic molecules become excretable into: A) Urine only B) Bile C) Sweat D) Saliva | back 68 B. Bile |
front 69 Patients with UGT1A1 *28/*28 are at increased risk for adverse drug reactions because of reduced: A) Renal filtration B) Biliary formation C) Platelet aggregation D) P450 induction | back 69 B. Biliary formation |
front 70 Irinotecan is hydrolyzed by hepatic carboxylesterases into which cytotoxic metabolite? A) 5-FdUMP B) SN-38 C) Morphine D) Thioguanine | back 70 B. SN-38 |
front 71 SN-38 causes chemotherapy effects by inhibiting topoisomerase I, which terminates: A) DNA replication B) Protein folding C) Platelet aggregation D) Pyrimidine catabolism | back 71 A. DNA replication |
front 72 UGT1A1 *28 increases irinotecan toxicity because SN-38 inactivation depends on which enzyme? A) CYP2C19 B) DPD C) UGT1A1 D) TPMT | back 72 C. UGT1A1 |
front 73 Phase I reactions mediated by hepatic P450 enzymes commonly modify functional groups such as OH, SH, NH2, and: A) OCH3 B) PAPS C) HGPRTase D) HLA | back 73 A. OCH3 |
front 74 CYP2D6 is involved in metabolism of about 25% of drugs and generally handles which type of compounds? A) Neutral compounds B) Basic compounds C) Steroid compounds D) Sulfated compounds | back 74 B. Basic compounds |
front 75 CYP2C19 is known to preferentially metabolize which type of drugs? A) Basic drugs B) Neutral drugs C) Acidic drugs D) Protein drugs | back 75 C. Acidic drugs |
front 76 Which drug class is among the acidic drug classes preferentially metabolized by CYP2C19? A) Proton-pump inhibitors B) Thiopurine drugs C) Statin drugs D) Opioid analgesics | back 76 A. Proton-pump inhibitors |
front 77 Which cytochrome P450 enzyme is used to metabolize HIV drugs? A) CYP2C9 B) CYP2D6 C) CYP2B6 D) CYP1A2 | back 77 C. CYP2B6 |
front 78 Dihydropyrimidine dehydrogenase is encoded by which gene? A) DPYD B) G6PD C) UGT1A1 D) CYP2C9 | back 78 A. DPYD |
front 79 Phase II biotransformation reactions generally do what to drugs or metabolites A) Oxidize heme iron B) Remove introns C) Reduce oxygen D) Conjugate endogenous molecules | back 79 D. Conjugate endogenous molecules |
front 80 Which gene is involved in pharmacologic deactivation of thiopurines? A) CYP2D6 B) DPYD C) OATP1B1 D) TPMT | back 80 D. TPMT |
front 81 TPMT is most directly involved in deactivation of which drug class? A) Antiplatelets B) Thiopurines C) Statins D) Opioids | back 81 B. Thiopurines |
front 82 The gene encoding G6PD is located on which chromosome? A) Chromosome 7 B) Chromosome 12 C) X chromosome D) Y chromosome | back 82 C. X chromosome |
front 83 Because G6PD is encoded on the X chromosome, G6PD deficiency classically follows which inheritance pattern? A) X-linked pattern B) Autosomal dominant pattern C) Autosomal recessive pattern D) Mitochondrial pattern | back 83 A. X-linked pattern |
front 84 Transport of statins into hepatocytes is mediated by which transporter? A) BCRP B) P-glycoprotein C) CFTR D) OATP1B1 | back 84 D. OATP1B1 |
front 85 Warfarin is metabolized primarily by which phase I enzyme? A) CYP3A4 B) CYP2D6 C) CYP2C9 D) CYP2B6 | back 85 C. CYP2C9 |
front 86 Epigenomics refers to heritable patterns of gene expression not attributable to changes in what? A) Primary DNA sequence B) Drug dose C) Protein folding D) Hepatic blood flow | back 86 A. Primary DNA sequence |
front 87 Which pair represents classic examples of epigenomic regulation? A) SNPs and CNVs B) DNA methylation and histone modifications C) Haplotypes and alleles D) Oxidation and reduction | back 87 B. DNA methylation and histone modifications |
front 88 A patient has VKORC1 -1639G>A plus CYP2C9 *2 or *3 and receives a normal warfarin dose. What risk increases? A) Clopidogrel failure B) Codeine toxicity C) Gilbert syndrome D) Bleeding | back 88 D. Bleeding |
front 89 Abacavir hypersensitivity reactions are associated with which HLA allele variant? A) HLA-B*57:01 B) HLA-B*27:05 C) HLA-DQ2 D) HLA-DR4 | back 89 A. HLA-B*57:01 |
front 90 Flucloxacillin-induced liver toxicity is associated with which HLA polymorphism? A) HLA-DQ8 B) HLA-DR3 C) HLA-B*57:01 D) HLA-A*31:01 | back 90 C. HLA-B*57:01 |
front 91 A 62-year-old woman with advanced colon cancer is treated | back 91 (D) DPYD*2A |
front 92 A 38-year-old man is being treated for HIV-induced acquired
| back 92 (C) HLA-B*57:01 (EM) |
front 93 Which of the following polymorphisms is associated with risk of
hemolysis and increased resistance to malaria? | back 93 (E) G6PD-(A)–Canton |
front 94 A 7-year-old child is brought to the emergency department in
| back 94 (A) CYP2D6*1x3 |